It's Mississippi State vs Memphis this college baseball season. Follow for live score updates and game highlights from Dudy ...

Q1 2025 Management View CEO David Zaccardelli highlighted the continued success of the Ohtuvayre launch for COPD maintenance treatment, with net product sales of $71.3 million in Q1 2025, nearly ...

Unlike other companies grappling with evolving trade policy, Pfizer did not revise its full-year outlook on Tuesday.

A Cambridge-based pharmaceutical company reported to the state that it is laying off close to a hundred employees.

CEO Albert Bourla is waiting for the US government to decide whether to place a 25% tariff on pharmaceutical imports.

Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the company of paying ...

The company CEO said he’s had “productive discussions” with Trump administration officials on a recently launched trade probe ...

We recently published a list of Billionaire Andreas Halvorsen’s 10 Stock Picks With Huge Upside Potential. In this article, ...

BAMCO, Inc. is an investment adviser registered with the U.S. Securities and Exchange Commission (SEC). Baron Capital, Inc.

Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...

AstraZeneca expects only limited impact from potential U.S. tariffs on pharmaceutical imports, the drugmaker said on Tuesday, ...

Novartis has a lot cooking with new drug launches, and the company is not letting potential U.S. tariffs on pharmaceuticals ...